Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial
| Autor: | Kadia, Tapan M *, Reville, Patrick K, Borthakur, Gautam, Yilmaz, Musa, Kornblau, Steven, Alvarado, Yesid, Dinardo, Courtney D, Daver, Naval, Jain, Nitin, Pemmaraju, Naveen, Short, Nicholas, Wang, Sa A, Tidwell, Rebecca S S, Islam, Rabiul, Konopleva, Marina, Garcia-Manero, Guillermo, Ravandi, Farhad, Kantarjian, Hagop M |
|---|---|
| Zdroj: | In The Lancet Haematology August 2021 8(8):e552-e561 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|